MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Chronic inflammation can help nurture skin cancer

Back to cancer blog Blogs list Cancer blog  


Subscribe To Cancer Blog RSS Feed  RSS content feed What is RSS feed?

Chronic inflammation can help nurture skin cancer




Inflammation, a frontline defense against infection or disease, can help nurture skin cancer, scientists have found.

IDO, an enzyme that works like a firefighter to keep inflammation under control, can be commandeered to protect early cancerous cells, say Medical College of Georgia scientists studying an animal model of chronic inflammation and skin cancer.

"Inflammation should really help prevent a tumor," says Dr. Andrew Mellor, director of the MCG Immunotherapy Center and Georgia Research Alliance Eminent Scholar in Molecular Immunogenetics. In fact, there is good evidence that inflammation triggers the immune response. "You want a good immune response; this is what protects you from pathogens," he says. "In this case, it's an unfortunate exploitation by cancerous cells".



Chronic inflammation can help nurture skin cancer

In a study with Drs. George C. Prendergast and Alexander J. Muller at the Lankenau Institute of Medical Research in Philadelphia, scientists gave mice a single dose of a carcinogen at the same time they began painting a tiny portion of skin with a poison ivy derivative twice weekly for 20 weeks.

IDO quickly became part of the mix, creating a "suppressive" immune response that helped resulting premalignant cells grow into tumors, as per research published online in Proceedings of the National Academy of Sciences. When they used the same protocol in a mouse in which IDO had been genetically deleted, tumor development dropped off dramatically.

The scenario is analogous to chronic sun exposure and skin cancer, says Dr. Mellor, the study's corresponding author. Ultraviolet radiation in sunlight causes cancerous skin cells to appear but sun exposure also causes skin inflammation - evidenced by sunburn. The significance of the new study is that the scientists have shown that IDO, or indoleomine 2,3-dioxygenase, may be produced as a part of the inflammatory mix, which could then protect the cancerous skin cells. "'Chronic' is the key word," Dr. Mellor says, noting high melanoma rates in Australians, for example, who live deep in the southern hemisphere.

"We have long suspected that IDO is a component of certain kinds of inflammation that create suppression," says Dr. Mellor. IDO's "firefighter" role probably resulted from the body's need to control inflammation in areas such as the gastrointestinal tract. The GI tract is constantly bombarded by food and microbes which could lead to debilitating and deadly inflammation.

"You really set a fire," Dr. Mellor says of inflammation. In fact, the English word inflammation comes from the Latin word inflamatio, which means to set a fire. But instead of helping protect healthy tissue as it does in the GI tract, IDO becomes problematic in cancer.

The latest finding shows IDO has a more important and earlier role than we thought in tumor formation, says Dr. Mellor. He and colleague Dr. David Munn led a research team that 10 years ago showed fetuses use IDO to avoid rejection by the mother's immune system. They and others have subsequently shown that tumors, including melanoma, as well as infectious agents such as HIV also use IDO to escape an immune attack. "IDO favors the tumor: The immune system basically sits back and watches the tumor grow," says Dr. Mellor.

Transplant patients, who require generalized immune inhibitors to keep their transplanted organs, also can be victims of this suppressive inflammation, says Dr. Mellor, noting their high risk of lymphoma after a few years of treatment.

The IDO inhibitor they have been using for years in the lab is now under study in patients with breast cancer receiving chemotherapy. Drs. Mellor and Munn also have recruited Dr. Yukai He, cancer vaccine researcher, to MCG to work with them on how vaccines designed to direct an immune attack can work synergistically with the IDO inhibitor.


Posted by: Janet    Source




Did you know?
Inflammation, a frontline defense against infection or disease, can help nurture skin cancer, scientists have found. IDO, an enzyme that works like a firefighter to keep inflammation under control, can be commandeered to protect early cancerous cells, say Medical College of Georgia scientists studying an animal model of chronic inflammation and skin cancer.

Medicineworld.org: Chronic inflammation can help nurture skin cancer

Main Page| Cancer blog| Cancer blogs list| Lung cancer blog| Colon cancer blog| Prostate cancer blog| Breast cancer blog| Diabetes watch blog| Heart watch blog| Allergy blog| Bladder cancer blog| Cervical cancer blog| Colon cancer news blog| Diabetes news blog| Esophageal cancer blog| Gastric cancer blog| Health news blog| Heart news blog| Infectious disease blog| Kidney watch blog| Lung disease blog| Lung cancer news blog| Mesothelioma blog| Neurology blog| Breast cancer news blog| OBGYN blog| Ophthalmology blog| Ovarian cancer blog| Cancer news blog| Pancreas cancer blog| Pediatrics blog| Prostate cancer news blog| Psychology blog| Research blog| Rheumatology blog| Society news blog| Uterine cancer blog| Weight watch blog|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.